Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Population pharmacokinetic and exposure-response analyses of guanfacine in Japanese pediatric ADHD patients.

Tsuda Y, Matsuo Y, Matsumoto S, Wajima T.

Drug Metab Pharmacokinet. 2019 Jul 4. pii: S1347-4367(19)30017-5. doi: 10.1016/j.dmpk.2019.07.001. [Epub ahead of print]

PMID:
31563330
2.

Glyceraldehyde-3-phosphate dehydrogenase of Mycoplasma pneumoniae induces infection-related glomerulonephritis
.

Hirano D, Oda T, Ito A, Yamada A, Kakegawa D, Miwa S, Umeda C, Takemasa Y, Tokunaga A, Wajima T, Nakaminami H, Noguchi N, Ida H.

Clin Nephrol. 2019 Sep 9. doi: 10.5414/CN109786. [Epub ahead of print]

PMID:
31496514
3.

Effects of Food and Calcium Carbonate on the Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist.

Katsube T, Wajima T, Fukuhara T, Kano T.

Clin Ther. 2019 Sep;41(9):1747-1754.e2. doi: 10.1016/j.clinthera.2019.06.004. Epub 2019 Jul 11.

4.

Earlier generation quinolones can be useful in identifying Haemophilus influenzae strains with low susceptibility to quinolone isolated from paediatric patients.

Tanaka E, Wajima T, Noguchi N.

J Med Microbiol. 2019 Aug;68(8):1227-1232. doi: 10.1099/jmm.0.001027. Epub 2019 Jun 19.

PMID:
31215858
5.

Impact of the introduction of a 13-valent pneumococcal vaccine on pneumococcal serotypes in non-invasive isolates from 2007 to 2016 at a teaching hospital in Japan.

Suzuki S, Osato R, Wajima T, Hasebe T, Ishikawa H, Mitsumori H, Nakaminami H, Noguchi N.

J Med Microbiol. 2019 Jun;68(6):903-909. doi: 10.1099/jmm.0.000992. Epub 2019 May 15.

PMID:
31090535
6.
7.

Population Pharmacokinetics of Baloxavir Marboxil in Japanese Pediatric Influenza Patients.

Koshimichi H, Ishibashi T, Wajima T.

J Pharm Sci. 2019 Sep;108(9):3112-3117. doi: 10.1016/j.xphs.2019.04.010. Epub 2019 Apr 16.

PMID:
30998942
8.

Population Pharmacokinetics of Doripenem in Pediatric Patients and Monte-Carlo Pharmacokinetic-Pharmacodynamic Simulations for Dosing Regimen Assessment.

Matsuo Y, Ishibashi T, Matsumoto S, Katsube T, Wajima T.

J Pharm Sci. 2019 Sep;108(9):3099-3105. doi: 10.1016/j.xphs.2019.04.002. Epub 2019 Apr 8.

PMID:
30974120
9.

Tokiinshi, a traditional Japanese medicine (Kampo), suppresses Panton-Valentine leukocidin production in the methicillin-resistant Staphylococcus aureus USA300 clone.

Maezawa Y, Nakaminami H, Takadama S, Hayashi M, Wajima T, Nakase K, Yamada T, Ikoshi H, Noguchi N.

PLoS One. 2019 Mar 28;14(3):e0214470. doi: 10.1371/journal.pone.0214470. eCollection 2019.

10.

Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment.

Tanaka E, Hara N, Wajima T, Ochiai S, Seyama S, Shirai A, Shibata M, Shiro H, Natsume Y, Noguchi N.

J Glob Antimicrob Resist. 2019 Sep;18:104-108. doi: 10.1016/j.jgar.2019.01.017. Epub 2019 Feb 10.

PMID:
30753907
11.

Panax Notoginseng Extract Possesses Significant Antibacterial Activity against Pathogenic Streptococci.

Wajima T, Kinugawa R, Yamada T, Ikoshi H, Noguchi N.

Pharmacology. 2019;103(5-6):221-227. doi: 10.1159/000496830. Epub 2019 Jan 28.

PMID:
30690443
12.

Evaluation of in Vitro Bactericidal Activity of 1.5% Olanexidine Gluconate, a Novel Biguanide Antiseptic Agent.

Seyama S, Nishioka H, Nakaminami H, Nakase K, Wajima T, Hagi A, Noguchi N.

Biol Pharm Bull. 2019 Mar 1;42(3):512-515. doi: 10.1248/bpb.b18-00821. Epub 2018 Dec 20.

13.

Population Pharmacokinetic and Exposure-Response Analyses of Baloxavir Marboxil in Adults and Adolescents Including Patients With Influenza.

Koshimichi H, Tsuda Y, Ishibashi T, Wajima T.

J Pharm Sci. 2019 May;108(5):1896-1904. doi: 10.1016/j.xphs.2018.12.005. Epub 2018 Dec 15.

14.

Isolation of multidrug-resistant Haemophilus influenzae harbouring multiple exogenous genes from a patient diagnosed with acute sinusitis.

Hara N, Wajima T, Seyama S, Tanaka E, Shirai A, Shibata M, Natsume Y, Shiro H, Noguchi N.

J Infect Chemother. 2019 May;25(5):385-387. doi: 10.1016/j.jiac.2018.09.015. Epub 2018 Oct 25.

PMID:
30482699
15.

Absorption, distribution, metabolism, and excretion of radiolabeled naldemedine in healthy subjects.

Ohnishi S, Fukumura K, Kubota R, Wajima T.

Xenobiotica. 2019 Sep;49(9):1044-1053. doi: 10.1080/00498254.2018.1536815. Epub 2019 Jan 4.

PMID:
30351180
16.

Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010-2017.

Ubukata K, Takata M, Morozumi M, Chiba N, Wajima T, Hanada S, Shouji M, Sakuma M, Iwata S; Invasive Pneumococcal Diseases Surveillance Study Group.

Emerg Infect Dis. 2018 Nov;24(11):2010-2020. doi: 10.3201/eid2411.180326.

17.

Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings.

Koshimichi H, Ishibashi T, Kawaguchi N, Sato C, Kawasaki A, Wajima T.

Clin Drug Investig. 2018 Dec;38(12):1189-1196. doi: 10.1007/s40261-018-0710-9.

18.

Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine.

Kubota R, Fukumura K, Wajima T.

Pharm Res. 2018 Oct 2;35(11):225. doi: 10.1007/s11095-018-2501-7.

19.

Evaluation of Drug-Drug Interaction Potential between Baloxavir Marboxil and Oseltamivir in Healthy Subjects.

Kawaguchi N, Koshimichi H, Ishibashi T, Wajima T.

Clin Drug Investig. 2018 Nov;38(11):1053-1060. doi: 10.1007/s40261-018-0697-2.

PMID:
30203386
20.

Prognostic factors and hazard ratios in colorectal cancer patients over 80 years of age: a retrospective, 20-year, single institution review.

Shervani S, Lu G, Sager K, Wajima T, Wong L.

J Gastrointest Oncol. 2018 Apr;9(2):254-262. doi: 10.21037/jgo.2018.01.06.

21.

Characterization of SCCmec type IV methicillin-resistant Staphylococcus aureus clones increased in Japanese hospitals.

Nakaminami H, Takadama S, Ito A, Hasegawa M, Jono C, Noguchi M, Shoshi M, Wajima T, Fujii T, Maruyama H, Sakamoto H, Ito Y, Okamoto S, Masaki Y, Tsuchiya K, Nishinarita S, Noguchi N.

J Med Microbiol. 2018 Apr 20. doi: 10.1099/jmm.0.000735. [Epub ahead of print]

PMID:
29676727
22.

Drug-drug interaction of cefiderocol, a siderophore cephalosporin, via human drug transporters.

Katsube T, Miyazaki S, Narukawa Y, Hernandez-Illas M, Wajima T.

Eur J Clin Pharmacol. 2018 Jul;74(7):931-938. doi: 10.1007/s00228-018-2458-9. Epub 2018 Apr 7.

PMID:
29627897
24.

Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzae.

Seyama S, Wajima T, Nakaminami H, Noguchi N.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01337-17. doi: 10.1128/AAC.01337-17. Print 2017 Nov.

25.

Prevalence of skin infections caused by Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Japan, particularly in Ishigaki, Okinawa.

Takadama S, Nakaminami H, Aoki S, Akashi M, Wajima T, Ikeda M, Mochida A, Shimoe F, Kimura K, Matsuzaki Y, Sawamura D, Inaba Y, Oishi T, Nemoto O, Baba N, Noguchi N.

J Infect Chemother. 2017 Nov;23(11):800-803. doi: 10.1016/j.jiac.2017.04.016. Epub 2017 May 25.

PMID:
28552322
26.

Specific clones of Staphylococcus lugdunensis may be associated with colon carcinoma.

Noguchi N, Fukuzawa M, Wajima T, Yokose K, Suzuki M, Nakaminami H, Kawai T, Moriyasu F, Sasatsu M.

J Infect Public Health. 2018 Jan - Feb;11(1):39-42. doi: 10.1016/j.jiph.2017.03.012. Epub 2017 May 11.

27.

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Guanfacine Extended-Release Formulation in Healthy Japanese and Caucasian Male Adults.

Matsuo Y, Okita M, Ermer J, Wajima T.

Clin Drug Investig. 2017 Aug;37(8):745-753. doi: 10.1007/s40261-017-0527-y.

PMID:
28421383
28.

Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A)-authors' response.

Seyama S, Wajima T, Suzuki M, Ushio M, Fujii T, Noguchi N.

J Antimicrob Chemother. 2017 Jun 1;72(6):1846. doi: 10.1093/jac/dkx114. No abstract available.

PMID:
28407066
29.

Population pharmacokinetics of ospemifene and safety evaluation of pharmacokinetic alterations caused by intrinsic and extrinsic factors
.

Kubota R, Matsumoto S, Wajima T.

Int J Clin Pharmacol Ther. 2017 Apr;55(4):339-347. doi: 10.5414/CP202821.

PMID:
28128722
30.

Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A).

Seyama S, Wajima T, Suzuki M, Ushio M, Fujii T, Noguchi N.

J Antimicrob Chemother. 2017 Mar 1;72(3):948-949. doi: 10.1093/jac/dkw501. No abstract available.

PMID:
27999037
31.

Oldenlandia diffusa Extract Inhibits Biofilm Formation by Haemophilus influenzae Clinical Isolates.

Wajima T, Anzai Y, Yamada T, Ikoshi H, Noguchi N.

PLoS One. 2016 Nov 30;11(11):e0167335. doi: 10.1371/journal.pone.0167335. eCollection 2016.

32.

Rise in Haemophilus influenzae With Reduced Quinolone Susceptibility and Development of a Simple Screening Method.

Seyama S, Wajima T, Yanagisawa Y, Nakaminami H, Ushio M, Fujii T, Noguchi N.

Pediatr Infect Dis J. 2017 Mar;36(3):263-266. doi: 10.1097/INF.0000000000001415.

PMID:
27870809
33.

The modified Gingyo-san, a Chinese herbal medicine, has direct antibacterial effects against respiratory pathogens.

Yamada T, Wajima T, Nakaminami H, Kobayashi K, Ikoshi H, Noguchi N.

BMC Complement Altern Med. 2016 Nov 14;16(1):463.

34.

Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function.

Katsube T, Wajima T, Ishibashi T, Arjona Ferreira JC, Echols R.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01381-16. doi: 10.1128/AAC.01381-16. Print 2017 Jan.

35.
36.

Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.

Morozumi M, Wajima T, Takata M, Iwata S, Ubukata K.

J Clin Microbiol. 2016 Nov;54(11):2695-2700. Epub 2016 Aug 24.

37.

Prevalence of macrolide-non-susceptible isolates among β-lactamase-negative ampicillin-resistant Haemophilus influenzae in a tertiary care hospital in Japan.

Wajima T, Seyama S, Nakamura Y, Kashima C, Nakaminami H, Ushio M, Fujii T, Noguchi N.

J Glob Antimicrob Resist. 2016 Sep;6:22-26. doi: 10.1016/j.jgar.2016.01.014. Epub 2016 Mar 22.

PMID:
27530834
38.

Impact of calcium concentration in Muller-Hinton medium on the antimicrobial activity of daptomycin.

Ito A, Nakaminami H, Wajima T, Noguchi N.

J Glob Antimicrob Resist. 2016 Mar;4:76-77. doi: 10.1016/j.jgar.2015.11.002. Epub 2015 Nov 30. No abstract available.

PMID:
27436401
39.

Correction: Host Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal Disease.

Hanada S, Iwata S, Kishi K, Morozumi M, Chiba N, Wajima T, Takata M, Ubukata K; Invasive Pneumococcal Diseases Surveillance Study Group.

PLoS One. 2016 Mar 31;11(3):e0153109. doi: 10.1371/journal.pone.0153109. eCollection 2016. No abstract available.

40.

Clarithromycin Resistance Mechanisms of Epidemic β-Lactamase-Nonproducing Ampicillin-Resistant Haemophilus influenzae Strains in Japan.

Seyama S, Wajima T, Nakaminami H, Noguchi N.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):3207-10. doi: 10.1128/AAC.00163-16. Print 2016 May.

41.

Functional Role of N- and C-Terminal Amino Acids in the Structural Subunits of Colonization Factor CS6 Expressed by Enterotoxigenic Escherichia coli.

Debnath A, Sabui S, Wajima T, Hamabata T, Banerjee R, Chatterjee NS.

J Bacteriol. 2016 Apr 14;198(9):1429-41. doi: 10.1128/JB.00657-15. Print 2016 May.

42.

Host Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal Disease.

Hanada S, Iwata S, Kishi K, Morozumi M, Chiba N, Wajima T, Takata M, Ubukata K; Invasive Pneumococcal Diseases Surveillance Study Group.

PLoS One. 2016 Jan 27;11(1):e0147877. doi: 10.1371/journal.pone.0147877. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0153109.

43.

Molecular Characterization of Invasive Streptococcus dysgalactiae subsp. equisimilis, Japan.

Wajima T, Morozumi M, Hanada S, Sunaoshi K, Chiba N, Iwata S, Ubukata K.

Emerg Infect Dis. 2016 Feb;22(2):247-54. doi: 10.3201/eid2202.141732.

44.

Characterization of unstable pEntYN10 from enterotoxigenic Escherichia coli (ETEC) O169:H41.

Ban E, Yoshida Y, Wakushima M, Wajima T, Hamabata T, Ichikawa N, Abe H, Horiguchi Y, Hara-Kudo Y, Kage-Nakadai E, Yamamoto T, Wada T, Nishikawa Y.

Virulence. 2015;6(8):735-44. doi: 10.1080/21505594.2015.1094606.

45.

Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010-2013.

Ubukata K, Chiba N, Hanada S, Morozumi M, Wajima T, Shouji M, Iwata S; Invasive Pneumococcal Diseases Surveillance Study Group.

Emerg Infect Dis. 2015 Nov;21(11):1956-65. doi: 10.3201/eid2111.142029.

46.

Characterization of oligomeric assembly of colonization factor CS6 from enterotoxigenic Escherichia coli.

Sabui S, Debnath A, Ghosal A, Wajima T, Hamabata T, Ramamurthy T, Ghosh AN, Basak S, Chatterjee NS.

Microbiology. 2016 Jan;162(1):72-83. doi: 10.1099/mic.0.000180. Epub 2015 Sep 16.

PMID:
26383084
47.

Population pharmacokinetics of peramivir in healthy volunteers and influenza patients.

Matsuo Y, Ishibashi T, Hollister AS, Wajima T.

Antimicrob Agents Chemother. 2015 Nov;59(11):6755-62. doi: 10.1128/AAC.00799-15. Epub 2015 Aug 17.

48.

Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol.

Song IH, Borland J, Chen S, Wajima T, Peppercorn AF, Piscitelli SC.

Ann Pharmacother. 2015 Jul;49(7):784-9. doi: 10.1177/1060028015580637. Epub 2015 Apr 10.

49.

Prediction of Pharmacokinetics and Pharmacodynamics of Doripenem in Pediatric Patients.

Matsuo Y, Ishibashi T, Shimamura K, Wajima T.

J Pharm Sci. 2015 Sep;104(9):3194-8. doi: 10.1002/jps.24432. Epub 2015 Mar 26.

PMID:
25821174
50.

Two specific amino acid variations in colonization factor CS6 subtypes of enterotoxigenic Escherichia coli results in differential binding and pathogenicity.

Debnath A, Wajima T, Sabui S, Hamabata T, Ramamurthy T, Chatterjee NS.

Microbiology. 2015 Apr;161(Pt 4):865-74. doi: 10.1099/mic.0.000038. Epub 2015 Jan 29.

PMID:
25635273

Supplemental Content

Loading ...
Support Center